Document is current
Any future updates will be listed below
-
Authors
,
Quinlan, Erin Burke http://orcid.org/0000-0003-2927-1632
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Barker, Gareth J. http://orcid.org/0000-0002-5214-7421
Bokde, Arun L. W.
Bromberg, Uli http://orcid.org/0000-0003-4974-971X
Büchel, Christian
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta
Frouin, Vincent http://orcid.org/0000-0001-9360-6623
Garavan, Hugh
Heinz, Andreas
Brühl, Rüdiger
Martinot, Jean-Luc
Paillère Martinot, Marie-Laure
Nees, Frauke
Orfanos, Dimitri Papadopoulos http://orcid.org/0000-0002-1242-8990
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Fröhner, Juliane H.
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert
Schumann, Gunter http://orcid.org/0000-0002-7740-6469
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EV0711, AERIAL 01EE1406A, 01EE1406B)
Agence Nationale de la Recherche (AF12-NEUR0008-01 - WM2NA, ANR-12-SAMA-0004)
Science Foundation Ireland (16/ERCD/3797)
RCUK | Medical Research Council (MR/N000390/1)
EC | Horizon 2020 Framework Programme (695313)
EC | EC Seventh Framework Programm | FP7 Health (603016, 602450, 115300-2)
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
Svenska Forskningsrådet Formas (259-2012-23)
- License Information
-
More Information
Article History
Received: 29 April 2019
Revised: 16 July 2019
Accepted: 19 August 2019
First Online: 1 November 2019
Compliance with ethical standards
:
: TB has served as an advisor or consultant to Actelion, Hexal Pharma, Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Lundbeck, Medice, Neurim Pharmaceuticals, Novartis, Pfizer, and Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, and Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire and Viforpharma; he received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. GJB has received honoraria from General Electric Healthcare for teaching on scanner programming courses and acts as a consultant for IXICO. The other authors report no biomedical financial interests or potential conflicts of interest.
